Physician Assistant Program year 2023 Source: CMS Open Payments, 2026 publication

Corey Yost

Physician Assistant Des Moines, IA Physician Assistant

NPI 1568020097 CMS profile 10577440

1221 Pleasant St Ste 100, Ste 100, Des Moines, IA 50309

Open in the dashboard

General payments

$125

1 record reported · program year 2023

Research payments

$0

Paid to them · None reported · program year 2023

Ownership & investment interest

$0

None reported

Through program year 2023, Corey Yost of Des Moines, IA is reported in the CMS Open Payments database as having received $125 across 1 general payment and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 29th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2023 General $125 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Corey Yost
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Corey Yost were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Corey Yost Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $125 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program year 2023
  1. Genentech USA, Inc. $125 1 payment

Every payment, record by record

What the payments were for General payments · program year 2023
  1. Food and Beverage $125 1 payment
Products named General payments · program year 2023
  1. LUNSUMIO $125 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

371

Median for Physician Assistant: 241

Drug cost

$169,048

Median for Physician Assistant: $4,110

Branded share of claims

23.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xtandi Enzalutamide Brand 11 $157,379
Xarelto Rivaroxaban Brand 12 $6,432
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 27 $1,492
Letrozole Generic 62 $1,020
Dexamethasone Generic 13 $361
Ondansetron Hcl Generic 28 $283
Hydroxyurea Generic 22 $267
Acyclovir Generic 15 $251
Anastrozole Generic 16 $241
Prochlorperazine Maleate Generic 19 $226

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 102 billing codes

Paid by Medicare

$631,188

Of which drugs: $602,386

Medicare patients

170

Average age 76

Services billed

31,555

107 women, 63 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 51%
Arthritis 41%
Chronic kidney disease 35%
Diabetes 29%
Depression 26%
Ischemic heart disease 24%
Osteoporosis 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, denosumab, 1 mg J0897 Office 17 2,220 $44,999
Injection, palonosetron hcl, 25 mcg J2469 Office 15 210 $126
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 23 560 $48
Injection, ondansetron hydrochloride, per 1 mg J2405 Office 20 376 $27
Injection, diphenhydramine hcl, up to 50 mg J1200 Office 11 21 $12

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record